HV
Hetalben Vikasbhai Shah
About Hetalben Vikasbhai Shah
Data last updated:
Hetalben Vikasbhai Shah is a Director at Centricure Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. Centricure Pharmaceuticals Private Limited reported revenue of ₹39.3 Lakh (FY 2025). Earlier, Hetalben Vikasbhai Shah was a Director at Vanmaur Enterprise Private Limited (2020–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jul 2023 | 2023 | ₹39.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jun 2020 | 2019 | ₹2.69 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hetalben Vikasbhai Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Binny Naishal Shah | 07981140 | Centricure Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hetalben Vikasbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hetalben Vikasbhai Shah
Hetalben Vikasbhai Shah currently holds 1 directorship: Centricure Pharmaceuticals Private Limited (Director, since 27 Jul 2023, revenue βΉ39.3 Lakh (FY 2025)).
Hetalben Vikasbhai Shah was first appointed on 30 Jun 2020 as Director at Vanmaur Enterprise Private Limited. The most recent appointment on record is 27 Jul 2023 at Centricure Pharmaceuticals Private Limited.
Hetalben Vikasbhai Shah held 1 earlier board appointment: Vanmaur Enterprise Private Limited (Director, 30 Jun 2020 to 19 Jul 2025).
The current boards of Hetalben Vikasbhai Shah's companies include Binny Naishal Shah (Centricure Pharmaceuticals Private Limited).